Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hermes Advanced Therapy Systems is a Taiwan-based healthcare technology company focused on advanced radiation oncology equipment, particularly proton therapy systems and related dosimetry and detector solutions. The company appears to operate primarily as a commercial-stage distributor and solutions provider rather than a drug developer, supporting project planning, equipment deployment, and customer support for cancer treatment centers. Hermes Advanced Therapy Systems has been identified as a subsidiary of Hermes-Epitek and has partnered with Mevion Medical Systems to distribute the MEVION S250i Proton Therapy System in Taiwan and parts of Southeast Asia. Its business is healthcare-related, but it is better categorized as a medtech and oncology equipment company than as a biotech or pharmaceutical developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hermes Advanced Therapy Systems.